Cyclic AMP and platelet prostaglandin synthesis
References (18)
- et al.
Platelet Aggregation
- et al.
Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets
Biochem. Biophys. Res. Commun.
(1976) - et al.
Metabolism of [14C] arachidonic acid by human platelets
Biochimica et Biophysica Acta
(1976) Phosphorous assay in column chromatography
J. Biol. Chem.
(1959)- et al.
Patterns of fatty acid release from endogenous substrates by human platelets, homogenates and membranes
J. Biol. Chem.
(1975) - et al.
Cyclic 3′5′-adenosine monophosphate in human blood platelets
- et al.
The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3′5′-cyclic monophosphate in platelets
Biochem. J.
(1971) Roles of cyclic nucleotides in platelet function
- et al.
Concepts of the blood platelet release reaction
Ser. Haemat.
(1971)
There are more references available in the full text version of this article.
Cited by (69)
Inhibition of platelet function by the endothelium
2019, PlateletsInhibition of Platelet Function by the Endothelium
2013, PlateletsInhibition of Platelet Function by the Endothelium
2012, Platelets, Third EditionInhibition of platelet function by the endothelium
2007, PlateletsInhibition of platelet function by the endothelium
2006, Platelets, Second EditionOxidized low-density lipoprotein (LDL) enhances thromboxane A<inf>2</inf> synthesis by platelets, but lysolecithin as a product of LDL oxidation has an inhibitory effect
2000, Prostaglandins and Other Lipid Mediators
Copyright © 1977 Published by Elsevier Inc.